Tb Clinical Trials
Here are the 6 most popular medical studies for tb
Behavioural Intervention
Stroboscopic Vision Training for Vision Impairment and Sports Performance
This trial is testing if stroboscopic vision goggles, which flicker to remove visual information for a brief moment, can enhance visual performance during a softball season for high school girls.
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation and Tregs Therapy for Kidney Transplant
This trial will test whether a combination of radiation and drugs followed by infusion of donor cells will allow recipients to eventually stop taking anti-rejection drugs after receiving a kidney from a living donor.
Behavioural Intervention
Relational Chatbot Physical Activity Intervention for Health Behaviors
This trial tests how a mobile app with a relational AI chatbot can improve physical activity behavior in people. It uses 5 types of relational messages during an intervention to promote positive human-AI relationships.
Popular filter options for tb trials
Concussion Clinical Trials
View 40 Concussion medical studies.
On-field activity group for Sports Injuries
This trial will involve two middle school football teams, with data being collected on 15-20 randomly selected players from each team. The aim is to develop an intervention to improve player safety, with data being collected before and after the season to measure any changes.
Procedure
Lumbar Drainage for Traumatic Brain Injury
This trial explores if ELD is safe & feasible for severe TBI patients without increasing risk of neurological worsening or herniation. Researchers will compare groups to see effects on raised intracranial pressure.
Behavioral Intervention
GOALS + BHE + fMRI for Traumatic Brain Injury
This trial will test whether training in self-regulation can help improve daily life for veterans with mild traumatic brain injury (TBI) and comorbid conditions. The study will also look at how these benefits relate to changes in cognitive and behavioral performance and brain networks.
Traumatic Brain Injury Clinical Trials
View 34 Traumatic Brain Injury medical studies.
On-field activity group for Sports Injuries
This trial will involve two middle school football teams, with data being collected on 15-20 randomly selected players from each team. The aim is to develop an intervention to improve player safety, with data being collected before and after the season to measure any changes.
Procedure
Lumbar Drainage for Traumatic Brain Injury
This trial explores if ELD is safe & feasible for severe TBI patients without increasing risk of neurological worsening or herniation. Researchers will compare groups to see effects on raised intracranial pressure.
Behavioral Intervention
GOALS + BHE + fMRI for Traumatic Brain Injury
This trial will test whether training in self-regulation can help improve daily life for veterans with mild traumatic brain injury (TBI) and comorbid conditions. The study will also look at how these benefits relate to changes in cognitive and behavioral performance and brain networks.
Phase 3 Tb Clinical Trials
View 98 phase 3 tb medical studies.
Enzyme Replacement Therapy
Cipaglucosidase Alfa + Miglustat for Pompe Disease
This trial will study the safety and effectiveness of Cipaglucosidase Alfa/Miglustat in treating Pompe disease in children who have either received enzyme replacement therapy before or have not.
Tb Clinical Trials With No Placebo
View 98 tb medical studies that do not have a placebo group.
Behavioral Intervention
Risk Factor Modification Program + Fitbit Monitoring for Prostate Cancer with Metabolic Syndrome
This trial is studying how well an exercise program and Fitbit monitoring work for managing metabolic syndrome and cardiovascular disease risk in prostate cancer patients receiving androgen deprivation therapy.
On-field activity group for Sports Injuries
This trial will involve two middle school football teams, with data being collected on 15-20 randomly selected players from each team. The aim is to develop an intervention to improve player safety, with data being collected before and after the season to measure any changes.
Alkylating agents
Cyclophosphamide + TBI + IMRT + Stem Cell Transplantation for Systemic Sclerosis
This trial is testing the side effects and feasibility of a new way to give total body radiation therapy (IMRT) with the chemotherapy drug cyclophosphamide before stem cell transplant to treat severe systemic sclerosis.
Antibiotic
PA-824 for Kidney Failure
This trial is a Phase I, open-label, single dose, sequential group study to compare the safety and pharmacokinetics of pretomanid in subjects with severe renal impairment including those with End Stage Renal Disease (ESRD) not needing dialysis, subjects with mild or moderate renal impairment, and subjects with normal renal function. The primary objective is to evaluate the PK profiles of pretomanid in plasma and urine after a single oral dose of 200 mg in subjects with renal impairment compared to matched healthy controls.
Paid Tb Clinical Trials
View 98 tb medical studies that offer remuneration.
Antibiotic
PA-824 for Kidney Failure
This trial is a Phase I, open-label, single dose, sequential group study to compare the safety and pharmacokinetics of pretomanid in subjects with severe renal impairment including those with End Stage Renal Disease (ESRD) not needing dialysis, subjects with mild or moderate renal impairment, and subjects with normal renal function. The primary objective is to evaluate the PK profiles of pretomanid in plasma and urine after a single oral dose of 200 mg in subjects with renal impairment compared to matched healthy controls.
View More Tb Trials
See another 68 many medical studies focused on tb.
Frequently Asked Questions
Introduction to tb
What are the top hospitals conducting tb research?
While tuberculosis (TB) may not be as commonly discussed as some other diseases, pioneering hospitals are actively engaged in clinical trials to combat this global health threat. In East Hanover, the Kessler Foundation is making strides with four ongoing TB trials. Although they have yet to conduct any previous trials on TB, their dedication and commitment to finding effective treatments are evident. Similarly, the City of Hope Medical Center in Duarte has three active TB trials underway and no prior history of conducting such studies.
The National Institutes of Health Clinical Center in Bethesda has also dedicated its resources to tackle this infectious disease. With three currently active TB trials and a cumulative total of five completed studies since their first recorded trial back in 2011, they continue to contribute valuable knowledge towards understanding and combating TB.
Meanwhile, the Kessler Foundation in West Orange is actively engaged in three ongoing clinical trials for tuberculosis without any past records of conducting similar investigations. Lastly, at the University of Miami in sunny Miami itself focus lies upon two current tb cases under consideration; however without much past evidence found regarding tbs earlier experiments here.
These institutions exemplify both innovation and determination within the medical community's fight against tuberculosis—a serious condition affecting millions worldwide. Through these clinical trials conducted across various locations across the country like East Hanover or Duarte where patients might find themselves supported by cutting-edge research led by healthcare professionals who strive for better outcomes every single day.The collective efforts undertaken by these esteemed hospitals bring hope for advancements that will alleviate suffering caused by this persistent disease
Which are the best cities for tb clinical trials?
When it comes to TB clinical trials, several cities in the United States are at the forefront of research and development. Houston, Texas leads with 8 active trials focusing on a range of treatments such as DRL_RI (Proposed rituximab biosimilar), breast cancer, and Donepezil. Baltimore, Maryland closely follows with 8 ongoing studies exploring interventions like Asundexian and Emetine. Bethesda, Maryland also shows promise with 7 active trials investigating Total Body Irradiation (TBI), Pheripheral blood stem cells, and more. Seattle, Washington contributes to the field with 6 active trials including Bilingual Brain Injury, Washington contributes to the field with 6 active trials including Bilingual Brain Injury Education and outpatient Navigation for Hispanic families. Finally, Portland, Oregon offers its own contributions through ongoing studies on breast cancer and branched chain amino acids. These cities serve as important hubs for TB clinical research in their dedication to finding better treatment options for patients worldwide.
Which are the top treatments for tb being explored in clinical trials?
Clinical trials are actively exploring potential treatments for tuberculosis (TB), with one standout contender leading the pack. MK-7762, also known as TBD09, has emerged as a promising option in the fight against TB. Currently, there is one active trial dedicated to assessing its efficacy and safety. Despite being a newcomer on the scene since 2023, this innovative treatment shows great potential in potentially revolutionizing TB management and improving patient outcomes.
What are the most recent clinical trials for tb?
Recent clinical trials have brought new hope for the treatment of tuberculosis (TB). One notable study is focused on emetine, which has progressed to Phase 2 and Phase 3 trials as a potential therapy for TB. Another trial explores an experimental treatment in its early stages (Phase 1) that aims to address this infectious diseasen experimental treatment in its early stages (Phase 1) that aims to address this infectious disease. Additionally, researchers are investigating the use of pregnenolone as a possible intervention for TB, with promising results from Phase 2 trials. These advancements signify significant progress in our understanding and management of this global health issue.
What tb clinical trials were recently completed?
A recent milestone has been reached in tuberculosis (TB) research with the completion of a clinical trial investigating Imatinib, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID). In October 2020, this trial concluded, bringing us closer to potentially improved treatment options for TB. With ongoing efforts like these, researchers are dedicated to combatting this infectious diseasef Allergy and Infectious Diseases (NIAID). In October 2020, this trial concluded, bringing us closer to potentially improved treatment options for TB. With ongoing efforts like these, researchers are dedicated to combatting this infectious disease and making significant strides towards better outcomes for patients.